![]() |
市場調査レポート
商品コード
1607752
医療用プロペラントの世界市場:タイプ・用途・エンドユーザー (医療機器製造業者・CMO・研究ラボ)・地域別の予測 (~2032年)Global Medical Propellants Market Research Report Information by Type, By Application, By End User (Medical Device Companies, Contract Manufacturing Organization, and Research Laboratories) And by Region Forecast Till 2032 |
||||||
|
医療用プロペラントの世界市場:タイプ・用途・エンドユーザー (医療機器製造業者・CMO・研究ラボ)・地域別の予測 (~2032年) |
出版日: 2024年11月21日
発行: Market Research Future
ページ情報: 英文 116 Pages
納期: 即納可能
![]() |
世界の医療用プロペラントの市場規模は、2023年の2億7,000万米ドル、2024年の3億米ドルから、予測期間中は10.16%のCAGRで推移し、2032年には7億2,000万米ドルの規模に成長すると予測されています。
医療用プロペラントの市場は、慢性閉塞性肺疾患 (COPD) や喘息を含む呼吸器疾患の有病率の上昇によって大きな影響を受ける可能性があります。この影響とは、プロペラントを利用する吸入ベースの治療薬やデバイスへの需要の増加です。呼吸器系疾患が流行する中で、肺に薬剤を供給するために不可欠なデバイスである吸入器の需要が増加していますが、これらの吸入器は、薬剤を効果的に送達するためにプロペラントを使用しています。
地域別展望
北米地域が2023年に最大の市場シェアを示しています。また、成長率では、欧州が予測期間中にもっとも高いCAGRを示すと予測されています。
北米市場は力強い成長を特徴としており、これは支持的な規制環境、技術の進歩、ヘルスケア要件の増加によってもたらされています。また、研究開発への多額の投資と高度なヘルスケアインフラによって最先端の医療用プロペラントの開発が可能となっており、同地域市場を牽引しています。
欧州の医療用プロペラント市場の特徴は、プロペラント処方の開発が進んでいることです。欧州の製薬部門は成熟しており、強力な流通チャネル、提携、厳格な欧州規制の遵守が保証されています。このため、製品は高い安全性と有効性の基準を満たしており、消費者の信頼を得ています。高品質の吸入器に対する需要は、呼吸器疾患の有病率上昇を促進する高齢化によってさらに高まっています。
アジア太平洋地域も予測期間中、さまざまな主要要因によって力強い成長を示すと予測されています。医療用プロペラントを利用する高機能吸入器の需要は、中国、インド、日本などの国における医療インフラの急速な拡大や医療インフラへの投資の増加によって牽引されています。
当レポートでは、世界の医療用プロペラントの市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。
Global Medical Propellants Market Research Report Information by Type (HFA 134A, HFA 227EA, HFA152A), By Application (Press Metered Dose Inhalers, Breath Actuated Metered Dose Inhalers), By End User (Medical Device Companies, Contract Manufacturing Organization (CMO), and Research Laboratories) And by Region (North America, Europe, Asia-Pacific, And Rest Of The World) Forecast Till 2032
In 2023, the Medical Propellants Market was estimated to be worth USD 0.27 billion. The industry is anticipated to experience a compound annual growth rate (CAGR) of 10.16% from USD 0.30 billion in 2024 to USD 0.72 billion by 2032 during the forecast period (2024-2032). The global metered-dose inhaler market is experiencing growth due to the increasing prevalence of respiratory conditions, including chronic obstructive pulmonary disease and asthma, as well as technological innovation in inhalation devices.
There is a significant likelihood that the medical propellants market will be significantly affected by the rising prevalence of respiratory disorders, including chronic obstructive pulmonary disease (COPD) and asthma. This effect is primarily the result of an increase in the demand for inhalation-based remedies and devices that utilize propellants. The demand for inhalers, which are essential devices for delivering medication to the lungs, is on the rise as respiratory maladies become more prevalent. These inhalers employ propellants to ensure that the medication is delivered effectively.
Market segment insights
The Medical Propellants Market has been segmented into HFA 134A, HFA 227EA, and HFA-152A based on type.
The Market has been segmented into manual metered dose inhalers and breath metered dose inhalers based on application.
According to the end user, the market has been divided into three categories: medical device companies, contract manufacturing organizations (CMOs), and research laboratories.
Regional Perspectives
In 2023, the market share that North America possessed was the most significant. Nevertheless, Europe is anticipated to experience the most significant compound annual growth rate (CAGR) during the 2024-2032 forecast period.
Robust growth is the hallmark of the Medical Propellants market in North America, which is driven by a supportive regulatory environment, technological advancements, and increased healthcare requirements. Additionally, the market is driven by the development of state-of-the-art Medical Propellants, which is made possible by a substantial investment in research and development and a sophisticated healthcare infrastructure.
Europe, which is further divided into Germany, France, the United Kingdom, Italy, Spain, and the Rest of Europe, follows the Americas region. The Medical Propellants market in Europe is characterized by the ongoing development of propellant formulations. The pharmaceutical sector in Europe is mature, which guarantees a strong distribution channel, collaborations, and adherence to stringent European regulations. This ensures that the products meet high safety and efficacy standards, which instills confidence in consumers. The demand for sophisticated, high-quality inhalers is further exacerbated by the aging population, which is driving the rise in the prevalence of respiratory diseases.
Over the forecast period, the Asia-Pacific region is anticipated to experience robust development, which is driven by a variety of key factors. It is also projected to be the fastest-growing region. The demand for sophisticated inhalers that utilize medical propellants is being driven by the rapid expansion of healthcare infrastructure and the increasing investments in healthcare infrastructure in countries such as China, India, and Japan.
Koura (US), SRF (India), DAIKIN (Japan), Linde PLC (UK), Xiamen Juda Chemical & Equipment Co., Ltd. (China), Jiangsu July Chemical Co., Ltd. (China), Beijing Yuji Technology Development Co., Ltd. (China), Zhejiang Jushen New Material Technology Co., Ltd. (China), Zhejiang fotech international co., ltd. (China), and Changshu 3F Fluorochemical Industry Co., Ltd. (China) are among the key companies in the Medical Propellants Market.
A propellant is a substance used to propel a medication from an aerosol canister or inhaler. These propellants are typically gases that help deliver medication in a fine mist or spray to ensure it can be effectively inhaled or applied.